Archives: Search / 2014 / 2013 / 2012

201120102009200820072006200520042003200220012000

Category: 

Jul 29, 2014
62% Revenue Growth as Reimbursement and Testing Volumes Improve
Jul 21, 2014
New Data Supporting the Clinical Validity of Sequenom Laboratories' Noninvasive Prenatal Tests Presented at the 18th International Conference on Prenatal Diagnosis and Therapy
May 1, 2014
20% Year-Over-Year Increase in Total Revenues Led By Continued Growth in Diagnostic Services
Mar 5, 2014
Harry Hixson to Retire as Sequenom CEO
Feb 27, 2014
Record Quarterly and Annual Revenues; Annual Growth of 81% Over Prior Year
Jan 16, 2014
Nicox further expands North American diagnostic portfolio with access to the RetnaGene AMD test, a genetic laboratory-developed test to predict the risk of progressing to late-stage or “wet” age-related macular degeneration (AMD)
 

RSS
Contact Us

Sequenom, Inc.
Donna Nichols
Investor Relations
858-202-9028
investorrelations@
sequenom.com

Subscribe to News Alerts